GLO advised Jin Medical on the offering. Jin Medical International Limited executed an initial public offering of 1.25 million ordinary shares, at a public offering price...
Jin Medical’s Initial Public Offering
Connect Biopharma’s $219.9 Million Initial Public Offering
Latham & Watkins LLP and Maples and Calder represented Connect Biopharma in the transaction. Global Law Office and Davis Polk advised joint book-running managers. Connect Biopharma...